RFL
Rafael HoldingsยทNYSE
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
RFL Profile
Rafael Holdings, Inc.
A company that owns certain commercial real estate assets and investments in clinical and early stage pharmaceutical companies
520 Broad Street, Newark, New Jersey 07102
--
Rafael Holdings, Inc., a biotechnology company incorporated in Delaware, focuses on the development of pharmaceutical products and holds strategic interests in clinical and early-stage biotechnology and medical device companies. The company's lead clinical candidate is Trappsol Cyclo, a therapy being evaluated in pivotal Phase 3 clinical trials for the treatment of Niemann-Pick disease type C1 (NPC1), a rare and fatal genetic disorder that disrupts cholesterol metabolism.
